What is the diagnosis for a 10-year-old female patient presenting with pallor, splenomegaly, a total leukocyte count (TLC) of 30,000, severe anemia with a hemoglobin level of 5.6, no lymphadenopathy, elevated serum glutamic-pyruvic transaminase (SGPT) of 51, total serum bilirubin of 4.6 with unconjugated bilirubin of 3.6?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis: Hereditary Spherocytosis with Hemolytic Crisis

Based on the clinical presentation of a 10-year-old with severe anemia (Hb 5.6 g/dL), marked splenomegaly, leukocytosis (TLC 30,000), predominantly unconjugated hyperbilirubinemia (3.6 mg/dL unconjugated of 4.6 mg/dL total), and absence of lymphadenopathy, the most likely diagnosis is hereditary spherocytosis in hemolytic crisis. 1, 2, 3

Key Diagnostic Features Supporting This Diagnosis

Pattern of Hemolysis

  • Predominantly unconjugated hyperbilirubinemia (78% unconjugated) indicates extravascular hemolysis, which is characteristic of hereditary red cell membrane disorders rather than intrahepatic cholestasis or biliary obstruction 4, 2, 5
  • The elevated unconjugated bilirubin results from breakdown of hemoglobin by the reticuloendothelial system, primarily in the spleen 4
  • Splenomegaly is present in approximately 80% of patients with chronic hereditary hemolytic anemias and reflects the site of red cell destruction 4, 3

Clinical Presentation Consistent with Membranopathy

  • Pallor, anemia, splenomegaly, and jaundice form the classic tetrad of congenital hemolytic anemia 3
  • The absence of lymphadenopathy argues strongly against lymphoproliferative disorders (leukemia, lymphoma) or storage diseases, which typically present with generalized lymphadenopathy 1, 6
  • Leukocytosis (TLC 30,000) represents a physiologic bone marrow response to severe anemia rather than a primary hematologic malignancy 1

Age and Severity Pattern

  • Presentation at age 10 with severe manifestations is consistent with hereditary spherocytosis, which can present at any age from infancy through adolescence 4, 3
  • The severity of anemia (Hb 5.6 g/dL) suggests either a hemolytic crisis (often triggered by viral infection) or chronic severe disease 4, 7

Essential Confirmatory Testing Required

Immediate Laboratory Studies

  • Peripheral blood smear examination to identify spherocytes - this is the single most important diagnostic test and should never be skipped in any child with splenomegaly and anemia 1, 8, 5
  • Reticulocyte count - should be markedly elevated (typically >5-10%) indicating bone marrow compensation for hemolysis 2, 5, 9
  • Lactate dehydrogenase (LDH) - will be elevated as a marker of hemolysis 2, 5, 9
  • Haptoglobin - will be decreased or undetectable due to binding of free hemoglobin 2, 5, 9
  • Direct antiglobulin test (Coombs test) - must be negative to exclude autoimmune hemolytic anemia 4, 2, 5

Specialized Testing

  • Osmotic fragility test or eosin-5-maleimide (EMA) binding test - confirms hereditary spherocytosis by demonstrating increased red cell membrane fragility 3
  • Abdominal ultrasound - to confirm splenomegaly, assess splenic volume, and evaluate for gallstones (common complication) 1, 8

Critical Differential Diagnoses to Exclude

Malignant Causes (Must Be Ruled Out Urgently)

  • Chronic myeloid leukemia (CML) can present with marked splenomegaly and leukocytosis in children, but typically shows circulating blasts on peripheral smear and requires BCR::ABL1 testing 1, 6
  • Acute lymphoblastic leukemia (ALL) presents with lymphadenopathy in 20% of cases, which is absent here 6
  • The peripheral blood smear will definitively exclude leukemia by absence of blasts 1, 8

Other Hemolytic Anemias

  • Pyruvate kinase deficiency presents similarly with chronic hemolysis, splenomegaly, and unconjugated hyperbilirubinemia, but is distinguished by normal red cell morphology on smear and requires enzyme assay for diagnosis 4
  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency causes episodic rather than chronic hemolysis and is triggered by oxidative stress 2, 5
  • Autoimmune hemolytic anemia (AIHA) is excluded by negative direct antiglobulin test 4, 2

Storage Disorders (Less Likely Given Age and Presentation)

  • Acid sphingomyelinase deficiency (Niemann-Pick) typically presents before age 6 with failure to thrive, and would show characteristic foam cells on bone marrow examination 1, 6
  • The absence of developmental delay or neurologic symptoms argues against storage disorders 1

Interpretation of Liver Function Abnormalities

  • Mildly elevated SGPT (51 U/L) is common in chronic hemolytic states due to hepatic congestion from splenomegaly and does not indicate primary liver disease 4
  • The pattern of predominantly unconjugated hyperbilirubinemia (78% unconjugated) definitively excludes hepatocellular disease or biliary obstruction as primary causes 4
  • Gilbert syndrome co-inheritance can exacerbate hyperbilirubinemia in hereditary spherocytosis but does not change management 4

Management Implications

Immediate Management

  • Avoid transfusion to hemoglobin >10 g/dL as sequestered red cells in the enlarged spleen may be acutely released causing overtransfusion 1
  • Transfuse packed red blood cells cautiously to hemoglobin 7-8 g/dL if symptomatic 1
  • Evaluate for precipitating factors (viral infection, particularly parvovirus B19 which causes aplastic crisis) 4, 3

Definitive Treatment Considerations

  • Splenectomy is curative for hereditary spherocytosis, typically resulting in hemoglobin increase of 1-3 g/dL and elimination of transfusion requirements 4, 3
  • Splenectomy should be deferred until after age 5-6 years when possible to reduce infection risk 4
  • Pre-splenectomy vaccination (pneumococcal, meningococcal, Haemophilus influenzae type b) is mandatory 4

Long-term Monitoring

  • Monitor for gallstone formation with periodic ultrasound, as cholelithiasis develops in most patients by adolescence due to chronic hyperbilirubinemia 4, 7, 3
  • Cholecystectomy can be performed concurrently with splenectomy if gallstones are present 7, 3
  • Monitor iron status, as iron overload can occur even without transfusions in chronic hemolytic states 4

Common Pitfalls to Avoid

  • Do not assume immune thrombocytopenic purpura (ITP) if thrombocytopenia is present, as significant splenomegaly suggests an alternative diagnosis 8
  • Do not miss the peripheral smear examination - this is the most critical diagnostic step and directly visualizes spherocytes 1, 8, 5
  • Do not perform splenectomy without confirming the diagnosis, as splenectomy is contraindicated in some other hemolytic conditions like hereditary stomatocytosis due to thrombotic risk 4
  • Do not attribute all hyperbilirubinemia to Gilbert syndrome without excluding hemolysis, as the unconjugated fraction can be elevated in both conditions 4

References

Guideline

Diagnostic Approach to Hepatosplenomegaly with Severe Anemia in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hemolytic anemia.

American family physician, 2004

Research

Congenital Hemolytic Anemia.

The Medical clinics of North America, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hemolytic Anemia: Evaluation and Differential Diagnosis.

American family physician, 2018

Guideline

Hepatosplenomegaly with Lymphadenopathy in Children: Causes and Diagnostic Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

[Extreme hyperbilirubinemia associated with spherocytosis and choledocholithiasis].

Boletin medico del Hospital Infantil de Mexico, 1990

Guideline

Management of Mild Splenomegaly in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Hemolytic anemias. Diagnosis and management.

The Medical clinics of North America, 1992

Related Questions

What is the management approach for chronic hemolysis (chronic breakdown of red blood cells)?
What is the diagnosis and management for a patient with normocytic anemia, elevated Lactate Dehydrogenase (LDH), and a high reticulocyte (retic) count?
An 8-year-old girl, with a height and weight in the 10th percentile, presents with severe eye pain, scleral icterus, hepatomegaly, fever, tachycardia, and hypotension, along with laboratory findings of decreased haptoglobin and hemoglobin, what is the most likely diagnosis given her symptoms and lab results?
What is the best medication for a patient with hemolytic anemia, characterized by severe anemia (Hb: 68), elevated reticulocytes (4%), low haptoglobin, and high lactate dehydrogenase (LDH), who developed fatigue, abdominal pain, and jaundice after 3 days of hospital admission?
What labs and management are recommended for suspected hemolysis (breakdown of red blood cells)?
What is the most appropriate advice for a 12-week pregnant patient presenting for an antenatal visit?
What is the appropriate management for a 54-year-old woman with elevated liver enzymes, alkaline phosphatase, and ultrasound findings suggestive of biliary obstruction due to gallstones?
What is the appropriate usage and dosage of Metoprolol (beta-blocker) for adults with hypertension, angina, heart failure, or a history of heart attack?
What is the management plan for a pediatric patient with severe acute malnutrition on F75 (Formula 75) feeding?
What is the recommended dopamine dose for a patient in shock, considering factors such as weight, age, and medical history?
What is the appropriate dosage of Eliquis (apixaban) for a patient with a history of atrial fibrillation, arm venous thrombosis, and recent gastrointestinal bleeding, who was previously on therapeutic Fragmin (dalteparin) and is now being re-initiated on Eliquis at 2x2.5mg?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.